Source: BioPortfolio

ViroCyt: ViroCyt Develops Rapid Detection System for Enterovirus 71

NewsViroCyt has announced the addition of another member of its ViroTagÂportfolio of antibodybased detection reagents ViroTag EV71.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
100-250
Robert Kline's photo - President & CEO of ViroCyt

President & CEO

Robert Kline

CEO Approval Rating

69/100

Read more